CA2079171A1 - Composes a base de cyclohexapeptidylpropanolamine - Google Patents

Composes a base de cyclohexapeptidylpropanolamine

Info

Publication number
CA2079171A1
CA2079171A1 CA2079171A CA2079171A CA2079171A1 CA 2079171 A1 CA2079171 A1 CA 2079171A1 CA 2079171 A CA2079171 A CA 2079171A CA 2079171 A CA2079171 A CA 2079171A CA 2079171 A1 CA2079171 A1 CA 2079171A1
Authority
CA
Canada
Prior art keywords
cyclohexapeptidyl
propanolamine compounds
compounds
cyclohexapeptidyl propanolamine
nucleus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2079171A
Other languages
English (en)
Other versions
CA2079171C (fr
Inventor
Milton L. Hammond
Robert A. Zambias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2079171A1 publication Critical patent/CA2079171A1/fr
Application granted granted Critical
Publication of CA2079171C publication Critical patent/CA2079171C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002079171A 1991-10-01 1992-09-25 Composes a base de cyclohexapeptidylpropanolamine Expired - Fee Related CA2079171C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77101791A 1991-10-01 1991-10-01
US771,017 1991-10-01
US936,561 1992-09-03
US07/936,561 US5939384A (en) 1991-10-01 1992-09-03 Cyclohexapeptidyl propanolamine compounds

Publications (2)

Publication Number Publication Date
CA2079171A1 true CA2079171A1 (fr) 1993-04-02
CA2079171C CA2079171C (fr) 2000-10-03

Family

ID=27118384

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002079171A Expired - Fee Related CA2079171C (fr) 1991-10-01 1992-09-25 Composes a base de cyclohexapeptidylpropanolamine

Country Status (9)

Country Link
US (1) US5939384A (fr)
EP (1) EP0535959B1 (fr)
JP (1) JPH07121958B2 (fr)
AT (1) ATE147757T1 (fr)
CA (1) CA2079171C (fr)
DE (1) DE69216746T2 (fr)
DK (1) DK0535959T3 (fr)
ES (1) ES2098455T3 (fr)
GR (1) GR3022292T3 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5552521A (en) * 1995-02-10 1996-09-03 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
PT1073675E (pt) 1998-04-23 2007-03-30 Aventis Pharma Gmbh Processo para a conversão de péptidos da classe da equinocandina nos seus análogos monodesoxilo da c4-homotirosina
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
AUPR234400A0 (en) * 2000-12-28 2001-01-25 Fujisawa Pharmaceutical Co., Ltd. New compound
AR035808A1 (es) * 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
US7214768B2 (en) * 2002-04-08 2007-05-08 Merck & Co., Inc. Echinocandin process
US8048853B2 (en) * 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
EP3620462A1 (fr) 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Procédé de préparation de caspofungine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173629A (en) * 1975-07-08 1979-11-06 Sandoz Ltd. Antibiotic S 31794/F-1
BE851310A (fr) * 1976-02-12 1977-08-10 Sandoz Sa Nouveaux derives de la tetrahydro-equinocandine b
DE2742435A1 (de) * 1976-09-28 1978-04-06 Sandoz Ag Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4320054A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912H nucleus
US4931352A (en) * 1987-10-07 1990-06-05 Merck & Co., Inc. Antifungal fermentation product
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5310873A (en) * 1990-03-12 1994-05-10 Merck & Co., Inc. Cyclohexapeptide compound
CA2037957A1 (fr) * 1990-03-12 1991-09-13 Merck & Co., Inc. Composes de cyclohexapeptides n-acyles
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US5159059A (en) * 1990-05-29 1992-10-27 Merck & Co., Inc. Process for reduction of certain cyclohexapeptide compounds
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii

Also Published As

Publication number Publication date
JPH07121958B2 (ja) 1995-12-25
CA2079171C (fr) 2000-10-03
EP0535959A1 (fr) 1993-04-07
ATE147757T1 (de) 1997-02-15
ES2098455T3 (es) 1997-05-01
JPH06234795A (ja) 1994-08-23
DE69216746T2 (de) 1997-07-03
GR3022292T3 (en) 1997-04-30
DK0535959T3 (da) 1997-06-09
DE69216746D1 (de) 1997-02-27
US5939384A (en) 1999-08-17
EP0535959B1 (fr) 1997-01-15

Similar Documents

Publication Publication Date Title
EP0535967A3 (fr)
AU2047692A (en) Therapeutic amides
AU6270286A (en) Therapeutic nucleosides
AU662128B2 (en) New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments
CA2068324A1 (fr) Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
WO1989006649A3 (fr) Agents anti-bacteriens
AU2288992A (en) Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents
AU2165088A (en) Bacterial treatment to preserve hay quality by addition of microorganisms of the genus bacillus
AU5778090A (en) 11B-aryl-4-estrenes, process for their preparation as well as their use as pharmaceutical agents
CA2079171A1 (fr) Composes a base de cyclohexapeptidylpropanolamine
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
GR3019957T3 (en) Derivatives of substituted cyclohexane, their process of preparation and their application with the treatment of diseases
AU1412088A (en) Therapeutic nucleosides
AU3329293A (en) Method of imparting antimicrobial activity to an ophthalmic composition
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
AU1413788A (en) Dihydropyridinamides process for their preparation, and their use in medicaments
GR3015899T3 (en) Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T.
AU3027692A (en) Compositions for the treatment of mammalian diseases
ATE240350T1 (de) Hydroxypropionitril-cyclohexapeptide
PH27266A (en) WS7622, A,B,C and D substances and pharmaceutical composition containing same
GR3026590T3 (en) Antibiotics ge 37468 a, b and c.
GR3004095T3 (fr)
AU6600190A (en) Therapeutic compositions; methods for treatment of hiv infections
AU2827684A (en) Novel cephalosporin derivatives,pharmaceutical compositions containing the same,their use in therapy as antibiotics and aprocess for the preparation of the novel compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed